HansBiomed Corporation (KOSDAQ: 042520)

Market Cap	125.32B
Revenue (ttm)	80.64B
Net Income (ttm)	-9.49B
Shares Out	12.99M
EPS (ttm)	-752.85
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	27,318
Open	9,650
Previous Close	9,650
Day's Range	9,650 - 10,400
52-Week Range	8,700 - 23,250
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Dec 19, 2024

About HansBiomed

HansBiomed Corporation, together with its subsidiaries, engages in the research and development, production, and sale of medical materials for the procedure and the raw materials for medical supplies. The company provides ExFuse, a demineralized bone matrix with cancellous bone gel/putty; BellaFuse, a demineralized bone matrix; Genesis, a cancellous sponge block/filler; Pedi-Stick, a demineralized cortical bone stick; SureChip, a cancellous bone chip; OsteoGrow, a demineralized bone matrix inserter; BellaCell HD, an allograft dermal product tha...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 1990
• Employees: 127
• Stock Exchange: KOSDAQ
• Ticker Symbol: 042520